| Aβ | Amyloid beta |
| AGEs | Advanced glycation end products |
| BBB | Blood–brain barrier |
| BCCAO | Bilateral common carotid artery occlusion |
| CCA | Common carotid artery |
| DAB | 3,3′-Diaminobenzidine |
| DAPI | 4′,6-Diamidino-2-phenylindole |
| HMGB1 | High mobility group box 1 non-histone DNA-binding protein |
| ICH | Intracerebral hemorrhage |
| LPA | Lysophosphatidic acid |
| LPA1 | Lysophosphatidic acid receptor 1 |
| LPA5 | Lysophosphatidic acid receptor 5 |
| PFA | Paraformaldehyde |
| pMCAO | Permanent middle cerebral artery occlusion |
| qRT-PCR | Quantitative real-time PCR |
| RAGE | Receptor for advanced glycation end products |
| tMCAO | Transient middle cerebral artery occlusion |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.